Currently holds a position at Biohaven Pharmaceutical Holding Company Ltd
Position | Company | Period |
---|---|---|
Independent Director | Biohaven Pharmaceutical Holding Company Ltd | Feb. 1, 2017 - |
Independent Director | Invitae Corp | Sept. 1, 2010 - June 11, 2019 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2020-12-18 | 2020-12-16 |
Invitae Corp
(NVTA)
|
S Sale |
3,600
-100.0%
51.47185,280 USD |
3,600 -100.0% | 51.47 | 185,280 USD | |
2020-12-18 | 2020-12-16 |
Invitae Corp
(NVTA)
|
S Sale |
6,400
-64.0%
50.74324,723 USD |
6,400 -64.0% | 50.74 | 324,723 USD | |
2020-11-18 | 2020-11-16 |
Invitae Corp
(NVTA)
|
PS Planned sale |
7,117
-100.0%
47.05334,855 USD |
7,117 -100.0% | 47.05 | 334,855 USD | |
2020-11-18 | 2020-11-16 |
Invitae Corp
(NVTA)
|
PS Planned sale |
22,883
-76.3%
46.361,060,856 USD |
22,883 -76.3% | 46.36 | 1,060,856 USD | |
2020-07-16 | 2020-07-15 |
Invitae Corp
(NVTA)
|
S Sale |
6,829
-100.0%
34.24233,814 USD |
6,829 -100.0% | 34.24 | 233,814 USD | |
2020-07-16 | 2020-07-15 |
Invitae Corp
(NVTA)
|
S Sale |
3,171
-31.7%
33.44106,039 USD |
3,171 -31.7% | 33.44 | 106,039 USD | |
2020-01-24 | 2020-01-22 | PS Planned sale |
150
-10.7%
58.868,829 USD |
150 -10.7% | 58.86 | 8,829 USD | ||
2020-01-24 | 2020-01-22 | PS Planned sale |
200
-12.5%
58.0011,599 USD |
200 -12.5% | 58.00 | 11,599 USD | ||
2020-01-24 | 2020-01-22 | PS Planned sale |
671
-29.5%
56.9938,243 USD |
671 -29.5% | 56.99 | 38,243 USD | ||
2020-01-24 | 2020-01-22 | PS Planned sale |
500
-18.0%
55.9927,996 USD |
500 -18.0% | 55.99 | 27,996 USD | ||
2020-01-24 | 2020-01-22 | PS Planned sale |
500
-15.3%
54.9727,486 USD |
500 -15.3% | 54.97 | 27,486 USD | ||
2020-01-10 | 2020-01-09 | S Sale |
30,000
-100.0%
56.391,691,700 USD |
30,000 -100.0% | 56.39 | 1,691,700 USD | ||
2019-09-13 | 2019-09-11 | PS Planned sale |
10,000
-100.0%
45.00450,000 USD |
10,000 -100.0% | 45.00 | 450,000 USD | ||
2019-07-08 | 2019-07-03 |
Eidos Therapeutics Inc
(EIDX)
|
B Purchase |
882,353
+3.7%
29.9026,382,796 USD |
882,353 +3.7% | 29.90 | 26,382,796 USD | |
2019-05-29 | 2019-05-24 |
Eidos Therapeutics Inc
(EIDX)
|
B Purchase |
1,103,848
+4.9%
25.9328,622,779 USD |
1,103,848 +4.9% | 25.93 | 28,622,779 USD |